Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
GSI77 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00346 | 35126843 | World J Hepatol | Is there a role of lipid-lowering therapies in the management of fatty liver disease? | 2022 | Details |
A00412 | 35093608 | Mol Cell Proteomics | Integrated liver and plasma proteomics in obese mice reveals complex metabolic regulation. | 2022 | Details |
A00670 | 35008852 | Int J Mol Sci | Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases. | 2021 | Details |
A00980 | 34911556 | BMC Biol | Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress. | 2021 | Details |
A02346 | 34408183 | Sci Rep | Key features of the environment promoting liver cancer in the absence of cirrhosis. | 2021 | Details |
A02602 | 34314306 | Immunopharmacol Immunotoxicol | The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions. | 2021 | Details |
A02620 | 34307250 | Front Pediatr | Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2021 | Details |
A02815 | 34231659 | Arq Gastroenterol | PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. | 2021 | Details |
A03015 | 34163108 | World J Gastroenterol | Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. | 2021 | Details |
A03339 | 34036255 | JHEP Rep | Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. | 2021 | Details |
A03470 | 33991461 | Physiol Rep | Prevention of non-alcoholic steatohepatitis by long-term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. | 2021 | Details |
A03763 | 33871418 | Curr Opin Clin Nutr Metab Care | Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction. | 2021 | Details |
A03786 | 33864571 | Mol Cell Biochem | Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy. | 2021 | Details |
A03830 | 33855376 | Minerva Surg | NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. | 2021 | Details |
A03865 | 33839905 | Eur J Nutr | Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. | 2021 | Details |
A04770 | 33511275 | Clin Exp Hepatol | Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression. | 2020 | Details |
A05843 | 33102775 | JGH Open | Determining whether the effect of liraglutide on non-alcoholic fatty liver disease depends on reductions in the body mass index. | 2020 | Details |
A05844 | 33102766 | JGH Open | Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non-alcoholic fatty liver disease patients. | 2020 | Details |
A06068 | 33022287 | Food Chem Toxicol | MEHP/ethanol co-exposure favors the death of steatotic hepatocytes, possibly through CYP4A and ADH involvement. | 2020 | Details |
A07947 | 32302728 | J Hepatol | Exercise retards hepatocarcinogenesis in obese mice independently of weight control. | 2020 | Details |
A08381 | 32133676 | Aliment Pharmacol Ther | Modelling NAFLD disease burden in four Asian regions-2019-2030. | 2020 | Details |
A08558 | 32061598 | Gastroenterology | Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A08566 | 32059982 | J Hepatol | NAFLD as a driver of chronic kidney disease. | 2020 | Details |
A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
A09295 | 31802390 | Hepatol Int | New drugs for NAFLD: lessons from basic models to the clinic. | 2019 | Details |
A09827 | 31597406 | Cells | A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
A10147 | 31470067 | J Hepatol | Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. | 2019 | Details |
A10345 | 31380833 | J Vis Exp | Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells. | 2019 | Details |
A11768 | 30759275 | Mol Genet Genomics | Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model. | 2019 | Details |
A12529 | 30408605 | Contemp Clin Trials | European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale. | 2018 | Details |
A13731 | 29786565 | Philos Trans R Soc Lond B Biol Sci | Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. | 2018 | Details |
A14000 | 29649907 | Expert Opin Ther Pat | Farnesoid X receptor modulators 2014-present: a patent review. | 2018 | Details |
A14720 | 29271970 | AIDS Rev | Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk. | 2018 | Details |
A14722 | 29271504 | Aliment Pharmacol Ther | Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. | 2017 | Details |
A15736 | 28737568 | J Pediatr Gastroenterol Nutr | Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A17123 | 27980597 | Nutr Metab (Lond) | Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. | 2016 | Details |
A17324 | 27845265 | J Ethnopharmacol | The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. | 2016 | Details |
A17661 | 27680752 | Cell Biol Toxicol | Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health. | 2016 | Details |
A17745 | 27624887 | Gut | Epigenetics in liver disease: from biology to therapeutics. | 2016 | Details |
A17871 | 27512407 | Nutr Metab (Lond) | High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs. | 2016 | Details |
A18069 | 27372863 | Med Hypotheses | Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance. | 2016 | Details |
A18530 | 30288302 | Hepatol Med Policy | Editor-in-Chief's welcome to Hepatology, Medicine and Policy. | 2016 | Details |
A19204 | 26703719 | Nutrients | Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study. | 2015 | Details |
A19919 | 26265792 | Clin Sci (Lond) | Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. | 2015 | Details |
A20699 | 25790917 | Biochim Biophys Acta | Peroxisomes compensate hepatic lipid overflow in mice with fatty liver. | 2015 | Details |
A21009 | 25580206 | Frontline Gastroenterol | Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. | 2014 | Details |
A21908 | 24968737 | Endocrine | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. | 2014 | Details |
A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
A23067 | 24068459 | Eur J Pediatr | Pediatric non-alcoholic fatty liver disease: an increasing public health issue. | 2013 | Details |
A24409 | 22930399 | Hepatology | Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. | 2013 | Details |
A28774 | 35024320 | Acta Pharm Sin B | A small molecule UPR modulator for diabetes identified by high throughput screening. | 2021 | Details |
A29312 | 34269452 | Transfusion | Temperature mapping in an air ambulance helicopter: Implications for the delivery of pre-hospital transfusion. | 2021 | Details |
A30441 | 32441510 | ACS Nano | Targeted Delivery of Notch Inhibitor Attenuates Obesity-Induced Glucose Intolerance and Liver Fibrosis. | 2020 | Details |
A30655 | 32039387 | JHEP Rep | The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity. | 2019 | Details |
A30802 | 31757853 | Proc Natl Acad Sci U S A | Social behavior for autonomous vehicles. | 2019 | Details |
A30994 | 31418094 | Environ Monit Assess | Accurate total solar irradiance estimates under irradiance measurements scarcity scenarios. | 2019 | Details |
A31339 | 30763813 | Accid Anal Prev | Game theoretic model for lane changing: Incorporating conflict risks. | 2019 | Details |
A33205 | 26475278 | BMC Surg | Long-term prognosis after resection of cryptogenic hepatocellular carcinoma. | 2015 | Details |
A37113 | 16446999 | Arch Environ Contam Toxicol | Mercury concentrations in gonad, liver, and muscle of white sturgeon Acipenser transmontanus in the lower Columbia River. | 2006 | Details |
A37506 | 15526543 | Rom J Intern Med | The risk factors of fibrosis in nonalcoholic steatohepatitis. | 2002 | Details |
A42214 | 35199660 | Curr Opin Clin Nutr Metab Care | Maternal weight and gestational diabetes impacts on child health. | 2022 | Details |
A43974 | 30265151 | Am J Physiol Heart Circ Physiol | Western diet triggers Toll-like receptor 4 signaling-induced endothelial dysfunction in female Wistar rats. | 2018 | Details |
A44152 | 29570245 | Obesity (Silver Spring) | Nonnutritive Sweeteners in Weight Management and Chronic Disease: A Review. | 2018 | Details |
A44482 | 28489415 | Am J Respir Cell Mol Biol | Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis. | 2017 | Details |
A49473 | 35743140 | Int J Mol Sci | Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis. | 2022 | Details |
A49525 | 35726748 | Pediatr Obes | Possible prediction of obesity-related liver disease in children and adolescents using indices of body composition. | 2022 | Details |
A49684 | 35671973 | Mol Metab | Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH. | 2022 | Details |
A50128 | 35509867 | Acta Histochem Cytochem | Label-free Assessment of the Nascent State of Rat Non-alcoholic Fatty Liver Disease Using Spontaneous Raman Microscopy. | 2022 | Details |
A50667 | 35308229 | Front Pharmacol | Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies. | 2022 | Details |
A50771 | 35272137 | Biomed Pharmacother | The contribution of sterile inflammation to the fatty liver disease and the potential therapies. | 2022 | Details |
A50830 | 35121749 | Sci Rep | A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study. | 2022 | Details |
A51449 | 35317186 | World J Hepatol | Glycogen hepatopathy in type-1 diabetes mellitus: A case report. | 2022 | Details |
A52109 | 31103416 | Biochem Pharmacol | Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice. | 2019 | Details |
A52170 | 30464235 | Int J Obes (Lond) | Very low calorie diets are associated with transient ventricular impairment before reversal of diastolic dysfunction in obesity. | 2018 | Details |
A52311 | 28810615 | Exp Ther Med | Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry. | 2017 | Details |
A52436 | 27138913 | Diabetologia | Neuronal human BACE1 knockin induces systemic diabetes in mice. | 2016 | Details |
A52931 | 19376605 | J Hepatol | Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. | 2009 | Details |